Lung Cancer Chemotherapy: Delay After Surgery Shows Benefit, Study Says
Patients suffering from a common form of lung cancer may benefit from delayed lung cancer chemotherapy after surgery, a team of Yale researchers found. The study was published online by JAMA Oncology yesterday.
Specifically, the research discovers that patients who had surgery to remove tumors in their lungs still show significant health improvement even after up to four months of delay in chemotherapy.
Previously, most physicians recommend chemotherapy within six weeks after surgery. However, in some cases, patients are not fit to undergo the therapy within the recommended time due to post-operative complications.
Oncologists previously believed that the delay can deteriorate the patient's ability to positively react to chemotherapy. The recent study proves otherwise, the News Medical says.
Furthermore, the study shows that non-small cell lung carcinoma (NSCLC), one of the two major types of lung cancer, benefits in the delay by showing reduction in tumors and cancer in the lymph nodes.
According to Dr. Daniel J. Boffa, of the Yale School of Medicine, one of the authors of the study, they used data from patients in the National Cancer Database. They examined the relationship between the timing of postoperative chemotherapy and five-year mortality.
The study investigates 12,473 patients with stage I, II, or III cancer who underwent delayed lung cancer chemotherapy. The finding suggests that the initiation of chemotherapy between 57 and 127 days after surgery led to similar results as patients who started the therapy within six and nine weeks.
Furthermore, according to the Science Daily, delayed chemotherapy was found to lower the risk of deaths compared to those who do not get the treatment at all.
Each year, more patients die from lung cancer than from any other form of cancers combined including colon and breast cancer.
Despite stronger smoking cessation campaigns as reported earlier, majority of the population still smoke or are in the process of quitting. The addictive components of cigarettes and the changes it causes on decision making skills impact the decision of smokers to quit.
With the emergence of the study, oncologists now are better informed regarding the recommended time for lung cancer chemotherapy.
Lung Cancer Not Affected By Statins
Statins have been used to lower cholesterol and prevent heart disease. However, lung cancer has been found to be not affected by statins.
Swedish American Hospital Receives Lung Cancer Certification
A Gold Seal of Approval for lung cancer care has been awarded to the Swedish American Hospital recently. The certification recognizes the facility as an exceptional lung cancer treatment center.
Cooling Caps Might Prevent Hair Loss During Chemotheraphy
Cooling caps that could reduce hair loss are not usually used in the US due to the lack of approval from the FDA. However, researchers conducted trials on breast cancer patients using the cooling cap, some of the patients hair loss was lessen.
Breast Cancer Causes Father To Get Double Mastectomy
Just because men don't have enlarged breasts doesn't mean they can't have breast cancer. A father becomes the youngest male to undergo double breast removal surgery after both his father and uncle died of the disease.
Miracle Fruit Restores Cancer Patient's Appetite
A miracle fruit that could help cancer patients regain their sense of taste is highly in demand. This could also contribute to the recovery of cancer patients. Frequent eating could help their body acquire nutrition that helps them get better.
MORE IN ITECHPOST
Mobile Phone App Designed to Boost Physical Activity in Women Shows Promise in Trial
Activity trackers and mobile phone apps are all the rage, but do they really help users increase and maintain physical activity? A new study has found that one mobile phone app designed for inactive women did help when combined with an activity tracker and personal counseling.
AI and High-Performance Computing Extend Evolution to Superconductors
Materials by design: Argonne researchers use genetic algorithms for better superconductors.
Owners of thoroughbred stallions carefully breed prizewinning horses over generations to eke out fractions of a second in million-dollar races. Materials scientists have taken a page from that playbook, turning to the power of evolution and artificial selection to develop superconductors that can transmit electric current as efficiently as possible.